肝细胞肝癌基因治疗研究进展
摘要
肝细胞肝癌（HCC）的基因治疗成为近10年来的研究热点。现就近10年来肝细胞肝癌的基因治疗的研究进展综述如下。
出处
《现代医药卫生》
2010年第13期2004-2006,共3页
Journal of Modern Medicine & Health
二级参考文献13
-
1Shuang Ping Guo~1 Wen Liang Wang~1 Yu Qiang Zhai~2 Yi Ling Zhao~1 ~1Department of Pathology,Xijing Hospital of the Fourth Military Medical University,Xi’an,China ~2Department of Urology,the Central Hospital of Xi’an,China.Expression of nuclear factor-KB in hepatocellular carcinoma and its relation with the X protein of hepatitis B virus[J].World Journal of Gastroenterology,2001,7(3):340-344. 被引量：55
-
2Zhao-You Tang Liver Cancer Institute & Zhongshan Hospital of Fudan University Professor of Surgery Chairman.Liver Cancer Institute of Fudan University(previous Liver Cancer Institute of Shanghai Medical University)136 Yixueyuan Road,Zhongshan Hospital,Shanghai 200032,China..Hepatocellular Carcinoma-Cause,Treatment and Metastasis[J].World Journal of Gastroenterology,2001,7(4):445-454. 被引量：214
-
3Kim D, Martuza RL, Zwiebel J. Replication-selective virotherapy for cancer: Biological principles, risk management and future directions. Nature Med. 2001; 7:781.
-
4Xin Yuan Liu. A new anticancer strategy-genetic and virological treatnent of cancer. Chinese J Cancer Biother 2001; 8: 1.
-
5Zhao L, Gu J, Dong A, et al. Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer. Hum Gene Ther 2005; 16: 845-58.
-
6Griffith TS, Chin WA, Jackson GC, et al. Intracellular regulation of TRAIL-induced apoptosis inhuman melanoma cells. J.Immunol. 1998: 161: 2833-40.
-
7Pitti RM, Marsters SA, Ruppert S, et al. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996; 271: 12687-90.
-
8Liu XY, Qiu SB, Zou WG, et al. Effective gene-virotherapy for complete rradication of tumor mediated by the combination of hTRAIL (TNFSF 10) and plasminogen k5. Mol Ther 2005; 11:531-41.
-
9Pei Z, Chu L, Zou W, et al. An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice. Hepatology 2004; 39:1371-81.
-
10Zou W, Luo C, Zhang Z, et al. A novel oncolytic adenovirus targeting to telomerase activity in tumor cells with potent. Oncogene 2004; 23: 457-64.
共引文献52
-
1祁付珍,吴健雄.肝癌根治术后肝内复发的相关因素及预防[J].国外医学（肿瘤学分册）,2004,31(7):538-541. 被引量：3
-
2秦建民,刘淑琴,曾锦章,李慎菁,付晓勇,邱秀华,吴孟超,王红阳.Gankyrin expression during mouse embryogenesis[J].Journal of Medical Colleges of PLA(China),2004,19(4):201-204.
-
3杨诏旭,窦科峰,路凡,赵忠良.GST-Gankyrin融合蛋白的原核表达及抗体制备[J].第四军医大学学报,2005,26(11):965-967. 被引量：2
-
4杨诏旭,窦科峰,路凡,卢兹凡,赵忠良.抑制gankyrin的表达对肝癌细胞系HepG2增殖的影响[J].世界华人消化杂志,2005,13(8):988-992. 被引量：3
-
5杨诏旭,窦科峰,路凡,卢兹凡.ShRNA抑制gankyrin基因在肝癌细胞中表达的研究[J].中国医师杂志,2005,7(10):1297-1299. 被引量：1
-
6杨诏旭,窦科峰,路凡,赵忠良.Gankyrin在肝癌细胞系中的表达[J].中国现代医学杂志,2005,15(23):3580-3582.
-
7曹志成.肝癌的病因与诊疗研究进展[J].世界华人消化杂志,2006,14(18):1755-1761. 被引量：19
-
8刘新垣.癌症靶向治疗的最新进展[J].中华肿瘤防治杂志,2006,13(18):1361-1364. 被引量：19
-
9张燕捷,房静远.Gankyrin分子结构及其功能研究进展[J].肿瘤,2006,26(12):1124-1126. 被引量：4
-
10陆正华,沈锋.门静脉癌栓研究进展[J].中国微创外科杂志,2007,7(1):64-66. 被引量：6
-
1潘春秋.肺结核并存肺癌114例临床分析[J].贵州医药,2005,29(10):937-938. 被引量：4
-
2姜争,武林枫.胰腺癌中MUC4表达的作用及临床意义[J].国际遗传学杂志,2006,29(2):127-129. 被引量：3
-
3殷凯,包善华,谢敏.射频消融治疗胰腺癌[J].肝胆胰外科杂志,2008,20(4):302-304.
-
4朱星丽,黎功.肝细胞癌表皮生长因子受体及其靶向治疗研究进展[J].中国药房,2011,22(14):1321-1323. 被引量：2
-
5刘宇,周道安.非小细胞肺癌术后放疗研究进展[J].中国肿瘤,2008,17(5):383-385. 被引量：2
-
6徐大兴,李平.中晚期食管癌的中西医结合治疗研究进展[J].江西中医药,2017,48(1):78-80. 被引量：18
-
7樊庆胜,王茂强.原发性肝癌肿瘤标志物对疗效、转移和预后评估的研究进展[J].临床医学工程,2011,18(1):152-154. 被引量：9
-
8吕志刚,王建祯.椎管内肿瘤的诊断与治疗[J].实用神经疾病杂志,2005,8(3):62-63.
-
9张荫昌.胃癌癌前病变研究的30年进展[J].中国肿瘤,2001,10(7):406-407. 被引量：21
-
10冯娟,陶秀娟.非小细胞肺癌脑转移治疗的研究进展[J].中国肿瘤,2013,22(12):1015-1019.
